Research Professor
IMDEA Nanociencia, Spain
Prof. Álvaro Somoza obtained his PhD in Organic chemistry and, during his postdoctoral stays, was trained in nucleic acid chemistry, particularly siRNAs, at Stanford University and IRB Barcelona. In 2009, he joined IMDEA Nanociencia to work on nanomedicine-related projects, where modified nanoparticles (e.g., AuNPs, MNPs, Albumin) have been employed to develop therapies and sensors for multiple diseases, including uveal melanoma, pancreatic cancer, or Duchenne muscular dystrophy.
Disclosure information not submitted.
Gold Nanoparticles as Carriers of MicroRNA Mimics for Cancer Immunotherapy and Muscular Diseases
Tuesday, July 15, 2025
10:29 AM – 10:54 AM EDT